Biovertis AG Company Profile

23:29 EDT 21st September 2018 | BioPortfolio

Biovertis is a privately-held, Austrian biotechnology company focusing on the discovery and development of novel classes of small molecule antibacterials. The antibiotics market is currently dominated by drug classes that have been in use for decades. However, an alarming rise in pathogens that are resistant to these types of drugs has created an urgent, unmet medical need in this field. With an advanced pipeline of proprietary compounds, all of which are characterized by a novel therapeutic mode of action, Biovertis addresses exactly this demand. In addition, the Company runs a highly efficient drug discovery process based on structural biology yielding further novel antibiotic classes that recognize new therapeutic targets. Biovertis' team has dedicated drug development expertise to take its candidates efficiently forward through clinical trials. Oxaquin, the most advanced candidate, is scheduled to enter clinical development in mid-2006.


Campus Vienna Biocenter 6


Phone: 43 1 7989 303
Fax: 43 1 7989 303-400

News Articles [5 Associated News Articles listed on BioPortfolio]

TVM Raises White Flag On Biovertis & Morphochem

Denoive acquires from TVM Capital both Biovertis and Morphochem, plus a Phase II ready antibiotic asset, for an initial 4%...   

Deinove gets FDA fast-tracked C diff candidate through Biovertis acquisition

Shares in Paris-based biotech Deinove are trading almost a tenth higher for the day on news that it has…

Experts Challenge GSK Triple Inhaled COPD Therapy Claims

While GSK and collaborators publish findings from the IMPACT trial comparing once-daily single-inhaler triple versus dual therapy in patients with...   

Merck KGaA Down-Plays Further Deals After Consumer Health Sell-Off

The sale of the Merck KGaA consumer health business to Procter & Gamble could eventually give the German multinational greater...   

Rebates And Discounts Have A Big Impact On US Drug Prices, IQVIA Report Shows

A new US drug spending report from IQVIA parses out how rebates impact drug spending and explores affordability for patients...   

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [1 Associated Companies listed on BioPortfolio]

Biovertis AG

Biovertis is a privately-held, Austrian biotechnology company focusing on the discovery and development of novel classes of small molecule antibacterials. The antibiotics market is currently dominated...

More Information about "Biovertis AG" on BioPortfolio

We have published hundreds of Biovertis AG news stories on BioPortfolio along with dozens of Biovertis AG Clinical Trials and PubMed Articles about Biovertis AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biovertis AG Companies in our database. You can also find out about relevant Biovertis AG Drugs and Medications on this site too.

Quick Search


Relevant Topics

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record